MindWalk Holdings (HYFT) Net Income Growth (3y) (2023 - 2026)

MindWalk Holdings (HYFT) Net Income Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 84.25%
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 32.96%
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.59%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -46.86%
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 19.97%
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 13.80%
9 Abivax 94.26 Bn 94.26 Bn - -
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78 25.99%

Historic Data

Download Data
DateValue
Jan 31, 2026 25.99%
Oct 31, 2025 398.18%
Jul 31, 2025 28.14%
Apr 30, 2025 -306.28%
Jan 31, 2025 346.93%
Oct 31, 2024 476.55%
Jul 31, 2024 1,223.70%
Apr 30, 2024 -88.44%
Jan 31, 2024 -32.61%
Oct 31, 2023 -7.06%